MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$134,044K
EPS
-$4.3
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
121,199
General and administrative
24,620
Total operating expenses
145,819
Loss from operations
-145,819
Interest income
11,343
Income from transition services agreements
1,192
Change in fair value of participation right liability
725
Other income (expense)
-35
Total other income (expense), net
11,775
Net loss
-134,044
Basic EPS
-4.3
Diluted EPS
-4.3
Basic Average Shares
31,144,775
Diluted Average Shares
31,144,775
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Interest income$11,343K Income from transitionservices agreements$1,192K Net loss-$134,044K Total other income(expense), net$11,775K Change in fair value ofparticipation right liability$725K Other income(expense)-$35K Loss from operations-$145,819K Total operatingexpenses$145,819K Research and development$121,199K General andadministrative$24,620K

BridgeBio Oncology Therapeutics, Inc. (BBOT)

BridgeBio Oncology Therapeutics, Inc. (BBOT)